ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Nanodiamond-doxorubicin Complexes Improve Hepatic Ischemia/reperfusion Injury

A. Kobayashi, C. Grady, S. Duarte, V. Boominathan, S. Shrestha, A. Zarrinpar

Surgery, University of Florida, Gainesville, FL

Meeting: 2021 American Transplant Congress

Abstract number: 603

Keywords: Liver

Topic: Basic Science » Ischemia Reperfusion & Organ Rehabilitation

Session Information

Session Name: Ischemia Reperfusion & Organ Rehabilitation

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Hepatic ischemia/reperfusion injury (IRI) is a major inflammatory event in liver transplantation that is mediated by oxidative stress. Doxorubicin (DOX) can mitigate oxidative stress by inducing the expression of heme oxygenase-1; however its clinical use in IRI has been hampered by significant systemic toxicity. Nanodiamonds (ND) are carbon nanoparticles with potential to be high-affinity carriers for the selective delivery of anthracyclines, such as DOX, and thus mitigate the negative effects of systemic delivery. Here, we use ND-adsorbed DOX (NDX) and evaluate its efficacy in a mouse model of hepatic IRI.

*Methods: We used a well-established mouse model of partial hepatic IRI. Partial hepatic ischemia was produced in the left and median lobes for 90 minutes followed by 6 hours reperfusion. Male 8-12 week old Balb/c mice were separated into 6 cohorts; High-DOX (1mg/kg), Low-DOX (0.5mg/kg), ND, High-NDX (1mg/kg equivalent of DOX), Low-NDX (0.5mg/kg equivalent of DOX) and phosphate buffered saline (PBS) were intravenously administered 48 hours prior to inducing ischemic injury.

*Results: Plasma levels of aspartate alanine aminotransferase (AST) and alanine aminotransferase (ALT) at 6 hours after reperfusion were significantly lower in High-DOX and Low-NDX treated mice, when compared with those in PBS treated mice (P<0.05 and P<0.05, respectively). AST and ALT levels of the High-DOX and Low-NDX treated mice were comparable. Histological analysis showed significantly less congestion, necrosis, and vacuolization in the High-DOX and Low-NDX group compared with those in PBS groups as assessed by Suzuki score (P<0.05 and P<0.01, respectively). High-DOX and Low-DOX decreased the local infiltration of the inflammatory cells such as T cells, neutrophils, and macrophages, and it reduced the expression of proinflammatory cytokines and chemokines.Furthermore, apoptosis, as measured by the number of TUNEL positive hepatocytes, was also suppressed in PEG-IDO treated mice.

*Conclusions: The results in this study indicate that NDX complexes protects mice from local inflammation and liver damage induced by hepatic IRI with half the DOX dose. These results support the development of a more clinically effective strategy for DOX in liver transplantation.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Kobayashi A, Grady C, Duarte S, Boominathan V, Shrestha S, Zarrinpar A. Nanodiamond-doxorubicin Complexes Improve Hepatic Ischemia/reperfusion Injury [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/nanodiamond-doxorubicin-complexes-improve-hepatic-ischemia-reperfusion-injury-2/. Accessed May 30, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences